Finanical Statements
Egyptian International Pharmaceuticals (EIPICO) (PHAR.CA) Reports its Financial Results (Consolidated) for the Period from 01/01/2026 to 30/06/2026
Published at 16 August 2026 at 06:18Egyptian International Pharmaceuticals (EIPICO)Related stock:Egyptian International Pharmaceuticals (EIPICO) stockAll Egyptian International Pharmaceuticals (EIPICO) disclosures
Disclosure summary
Company Name: Egyptian International Pharmaceuticals (EIPICO)
ISIN Code: EGS38081C013
Currency: Egyptian Pound
F/S (Consolidated) Period: From 01/01/2026 to 30/06/2026
Net profit: 626,674,081
F/S (Consolidated) Period: From 01/01/2025 to 30/06/2025
Net Comparative profit: 828,064,852
Audit Status: Reviewed
Source: Egyptian International Pharmaceuticals (EIPICO)
Taking minority rights into consideration
The Financial Statements (2,392 KB)
The BoD Report (3,396 KB)
ISIN Code: EGS38081C013
Currency: Egyptian Pound
F/S (Consolidated) Period: From 01/01/2026 to 30/06/2026
Net profit: 626,674,081
F/S (Consolidated) Period: From 01/01/2025 to 30/06/2025
Net Comparative profit: 828,064,852
Audit Status: Reviewed
Source: Egyptian International Pharmaceuticals (EIPICO)
Taking minority rights into consideration
The Financial Statements (2,392 KB)
The BoD Report (3,396 KB)